OpportunityTitle: Molecular Characterization of Multiple Myeloma Ethnic Disparity
AdditionalInformationOnEligibility: Eligibility is limited to the Multiple Myeloma (MM) service of Memorial Sloan Kettering Cancer Institute.
Description: The goal of this funding opportunity is to determine the molecular characteristics of Multiple Myeloma (MM) in patients of Black ethnicity compared to those of White ethnicity. The project will support the FDA&apos;s scientific mission of protecting and promoting the public health by initiating and facilitating research into the observed differences in Blacks and the relevance to drug approval and future clinical trial design.
GrantorContactEmailDescription: vieda.hubbard@fda.hhs.gov
GrantorContactText: Vieda Hubbard &lt;br/&gt;Grants Management Specialist &lt;br/&gt;Phone 240-402-7588